Segall Bryant & Hamill, LLC Vbi Vaccines Inc Transaction History

Segall Bryant & Hamill, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$0.87 - $3.13 $14,790 - $53,210	-17,000 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$0.73 - $1.91 $3,650 - $9,550	-5,000 Reduced 22.73%	17,000 $16,000
Q4 2019 Feb 11, 2020	BUY	$0.48 - $1.38 $10,560 - $30,359	22,000 New	22,000 $30,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.